Quest Diagnostics Incorporated
Developing and administering laboratory-based tests.
Based in DC
🤖
AI Overview
With $1.8M in lobbying spend across 26 quarterly filings, Quest Diagnostics Incorporated is a significant lobbying presence.
$1.8M
Total Lobbying Spend
26
Quarterly Filings
1
Lobbying Firms Used
4
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $60K |
| 2019 | $240K |
| 2020 | $180K |
| 2021 | $240K |
| 2022 | $320K |
| 2023 | $320K |
| 2024 | $240K |
| 2025 | $240K |
Lobbying Firms
RED+BLUE STRATEGIES
What They Lobby For
- Issues related to innovation, access and affordability of laboratory-based health care modalities in the United States.
- Issues related to the promulgation of the Protecting Access to Medicare Act with a focus on ensuring the new reimbursement formulas are in line with beneficiary needs, differentiation in lab-performed tests and general practice guidelines.
- Issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
- H.R. 3584 - The Lab Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
- H.R. 3584 - The LAB Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
- H.R. 1865 - Further Consolidated Appropriations Act, 2020 - inclusion of policies regarding data collection from laboratories as dictated by the Protecting Access to Medicare Act (PAMA). H.R. 3584 - The Lab Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
- H.R. 1865 - Further Consolidated Appropriations Act, 2020 - inclusion of policies regarding data collection from laboratories as dictated by the Protecting Access to Medicare Act (PAMA). H.R. 3584 - The LAB Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
- Issues related to Administration policies on testing for COVID-19 as well as back to work protocols that include testing. H.R. 6800 - The HEROES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19. H.R. 6074 - Implementation - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis. H.R. 6201 - Implementation- Families First Coronavirus Response Act - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe. H.R. 748 - The CARES Act - Implementation- Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
- H.R. 6800 - The HEROES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19 for Medicare and Medicaid beneficiaries. H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Implementation - Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis. H.R. 6201 - Families First Coronavirus Response Act - Implementation - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe. H.R. 748 - The CARES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
- H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed. H.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19. Senate HEALS Act - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19. H.R. 6800 - The HEROES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19 for Medicare and Medicaid beneficiaries. H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Implementation - Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis. H.R. 6201 - Families First Coronavirus Response Act - Implementation - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe. H.R. 748 - The CARES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.